full

Bench-Top Centrifuges--Basic Tools for the Small Lab

... comes complete with a 45-degree angle rotor and a full set of standard shields. The device is designed with an integral 30-minute timer and accepts a variety of tube sizes up to 15 mL. This centrifuge also features a maintenance-free brushless motor and incorporates a power interrupt design for user saf...

Lab Automation Networks Proliferating

...nning with pre-analytic activity and proceeding to full laboratory integration. However, the company markets customized open system configurations that can connect 30 different models of instrumentation from a variety of manufacturers. The longest-standing firm supporting total laboratory automation is L...

Choosing Lab Quality Management Software

...de up of four facilities. This busy lab provides a full test menu with a combined test volume averaging 3,000,000 tests annually. Lab services are provided and supported by a staff that totals 104 FTEs. The Lakeridge Health lab faces many of the pressures familiar to todays labs: staff shortages, declinin...

Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer

...UX for the treatment of EGFR-expressing mCRC. For full prescribing information, including boxed WARNINGSregarding infusion reactions and cardiopulmonary arrest, visit<a target="_blank" href="http://www.erbitux.com/">http://www.ERBITUX.com . Important Safety Information Grade 3/4 infusion reacti...

Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis

...TM) on the pharmacokineticproperties of rVIIa The full poster presentations are available on the Neosecorporate website at:http://phx.corporate-ir.net/phoenix.zhtml?c=60494&p=irol-presentations About Coagulation Factor VII Factor VII/VIIa is used in the treatment of bleeding episodesand for the p...

Clinical Data Suggest Decreased Bleeding Risk in People With Severe Hemophilia A While Maintaining Factor VIII Levels Above One Percent

...es can obtain moreinformation on ADVATE, including full Prescribing Information, at<a target="_blank" href="http://www.advate.com/">http://www.ADVATE.com . Europeanhealthcare professionals can obtain information at <a target="_blank" href="http://www.emea.europa.eu/">http://www.emea.europa...

YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial

...: achievement of effective analgesia, completionof full dose, or onset of dose-limiting side effects. Patients wereallowed rescue medication at any time following initiation of studytreatment. For the first dose administered in the PACU, the percentage ofpatients reporting a pain intensity (PI) score o...

Rosetta Genomics to Webcast Presentation at CE Unterberg, Towbin Emerging Growth Opportunities Conference

...companies, Rosetta Genomics is working todevelop a full range of diagnostic and therapeutic products basedon microRNAs. The company's primary focus is in the development ofmicroRNA-based products to diagnose and treat different forms ofcancer and infectious diseases. For more information please visit:<...

Response Genetics Announces Publication of a Phase III Clinical Trial Demonstrating That Low Levels of ERCC-1 Help to Predict Likelihood of Response to Cisplatin-Based Therapy in Lung Cancer

...observed in the "genotypic" arm of the study. The full article will be made available on Response Genetics'website later this week. "There is tremendous value in better understandingpharmacogenomics to tailor treatment and improve patient outcomes,"said Kathleen Danenberg, President and CEO of Response ...

New Phase 3 Study Published in The Lancet Evaluates Efficacy and Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination Therapy in Treatment-Experienced Adults With HIV

...3percent), and vomiting (1.5 percent). Please see full Prescribing Information for more details. A copyof full Prescribing Information can be obtained by visitingPREZISTA.com. About PREZISTA PREZISTA was devel...

Peer Reviewed Journal Article Indicates Repros' Proellex Exhibits Potential for New Approach to the Treatment and Prevention of Breast Cancer

..."Our developmental portfolio of indications isvery full at this time. We believe the opportunity to find apartner in the oncology arena for the breast cancer indicationrepresents a great opportunity for the Company. We therefore planto explore a potential collaborative relationship with one of themajor on...

Rosetta Genomics and Weizmann Institute Scientists Identify Role of microRNA in Cancer Suppression

...companies, Rosetta Genomics is working todevelop a full range of diagnostic and therapeutic products basedon microRNAs. The company's primary focus is in the development ofmicroRNA-based products to diagnose and treat different forms ofcancer and infectious diseases. For more information please visit:<...

Avexa's Apricitabine Clinical Trial Update

...ty profile. To date, 14 patients have completedthe full 48 weeks on the trial, and 13 of these have elected tocontinue on apricitabine treatment in an extension study. Thelongest treated patient has successfully completed more than 18months of apricitabine therapy. One additional Serious AdverseEvent (hos...

Suven Life Sciences Presenting Pre-clinical data of their NCE’s SUVN-502 and SUVN-507at International Brain Research Organization (IBRO) 2007 World Congress of Neuroscience

...r collaborative research partners, ability tooffer full spectrum of services from discovery to market launch andprovide technologies and expertise in different therapeutic areas.Suven has R&D strength of more than 190 professionals with thestate of the art infrastructure for Drug Discovery and develop...

From Clinical Cancer Research: Rethinking Therapeutic Cancer Vaccine Trials

...and morethan 70 other countries. AACR marshals the full spectrum ofexpertise from the cancer community to accelerate progress in theprevention, diagnosis and treatment of cancer through high-qualityscientific and educational programs. It funds innovative,meritorious research grants. The AACR Annual Meetin...

Skin Rash Actually Signifies Better Outcomes for Pancreatic and Lung Cancer Patients

...and morethan 70 other countries. AACR marshals the full spectrum ofexpertise from the cancer community to accelerate progress in theprevention, diagnosis and treatment of cancer through high-qualityscientific and educational programs. It funds innovative,meritorious research grants. The AACR Annual Meetin...

Researchers Discover Method for Identifying How Cancer Evades the Immune System

...and morethan 70 other countries. AACR marshals the full spectrum ofexpertise from the cancer community to accelerate progress in theprevention, diagnosis and treatment of cancer through high-qualityscientific and educational programs. It funds innovative,meritorious research grants. The AACR Annual Meetin...

Common Preterm Labor Drug Has More Side Effects Than Alternative, Finds Study from Packard Children's Hospital and Stanford

...erspatients locally, regionally and nationally the full range ofhealth care programs and services -- from preventive and routinecare to the diagnosis and treatment of serious illness and injury.For more information, visit http://www.lpch.org. Contact for Stanford University Medical Center Print Media...

Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Quadramet at International Myeloma Workshop

...mmercial, andstrategic initiatives. A copy of the full prescribing information for CAPHOSOL,QUADRAMET, PROSTASCINT, and SOLTAMOX, including box warnings, maybe obtained in the U.S. from Cytogen Corporation by calling tollfree 800-833-3533 or by visiting Cytogen's web site atwww.cytogen.com. The Company's...

Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension

...unds designated as the SPP600 series.Speedel holds full development and commercialization rights forthese product candidates under the license agreement with Roche. IfSpeedel decides to offer rights to any Speedel compound from theseries to a third party, Roche has a right of first negotiationwith respect...

An Investigational Study Released at ADA Showed that Initial Combination Therapy with Januvia (sitagliptin) and Metformin Led to Improvement in Markers of Beta Cell Function in Patients with Type 2 Diabetes

...n needed to useJANUVIA safely and effectively. See full prescribing information forJANUVIA. JANUVIA(TM)...eling *Sections or subsections omitted from the full prescribinginformation are not listed. FULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE ...

Tranzyme Pharma Presents Initial Phase IIa Data for its Novel Ghrelin Agonist, TZP-101, in Patients with Diabetic Gastroparesis

...e I clinical studies. TheCompany plans to initiate full Phase II development of TZP-101 forboth POI and severe gastroparesis in 3Q 2007. In addition to theongoing clinical testing of TZP-101 (an intravenous drug), Tranzymeis developing a new oral ghrelin agonist, TZP-102. Tranzyme expectsto initiate Phase...

HepaLife's PBS-1 Cells for Influenza Vaccine Production Prove Superior at International Conference

...it:http://www.hepalife.com/alerts.php To view the full HTML text of this release, please visit:http://www.hepalife.com/20070625-1.html.php Legal Notice Regarding Forward-Looking Statements No statement herein should be considered an offer or asolicitation of an offer for the purchase or sale of anysecu...

Byetta Treatment for Three and a Half Years Associated with Reductions in Cardiovascular Risk Factors in People with Type 2 Diabetes

...thiazolidinedione, andprogressive weight loss. For full prescribing information, visit<a target="_blank" href="http://www.byetta.com/">www.BYETTA.com . About Diabetes Diabetes affects more than 20 million in the United States andan estimated 246 million adults worldwide.(3,4) Approximately 90-95...

Late Breaking Data Released at ADA Showed that the Investigational Use of Januvia and Metformin as Initial Combination Therapy Provided Significant Glucose Lowering Efficacy over 54 Weeks in Patients with Type 2 Diabetes

...n needed to useJANUVIA safely and effectively. See full prescribing information forJANUVIA. JANUVIA(TM)...eling *Sections or subsections omitted from the full prescribinginformation are not listed. FULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE ...

Interim Analysis of Crinone Pregnancy Study to Be Published in American Society for Reproductive Medicine Journal

...ent, patient-friendly, pre-filledapplicator." The full in-press article is available for purchase athttp://www.fertstert.org/article/PIIS0015028207005407/abstract andwill soon appear in the print version. About Fertility and Sterility Fertility and Sterility, known as "the red journal," publishesjuried...

Liraglutide provides significantly better glucose control than insulin glargine in phase 3 study

...e first quarter of 2008. Detailed results from the full LEAD(TM)programme are expected to be published in peer reviewed journalsand communicated at future scientific meetings. The results of the phase 3 trial do not change Novo Nordisk'sexpectations for the company's financial results for 2007, whichwer...

Amylin Pharmaceuticals to Present New Data from Broad Diabetes and Obesity Programs at ADA 2007

... on Monday, June 25 at 5:30 PM CT (6:30 PM ET). A full list of all Amylin abstracts being presented at ADA isavailable at: <a target="_blank" href="http://scientificsessions.diabetes.org/">http://scientificsessions.diabetes.org . FEATURED SYMPOSIA 1. "The Diabetes-Obesity Continuum: The G...

Avalon Pharmaceuticals Announces Positive Interim Results For AVN944 Phase I Trial

...e months of treatment and two others completed one full year oftreatment. One AML patient has completed 8 monthly cycles oftreatment. Positive Dose Dependent Biomarker Data: The AvalonRx(R) platformhas identified selected biomarkers from patient samples which showa correlation of changes in gene expressi...

New Data Presented on Micardis (Telmisartan) Tablets in Hypertensive Patients With Type 2 Diabetes

...ive effects of MICARDIS. For more information and full prescribing information, pleasevisit <a target="_blank" href="http://www.micardis.com/">www.MICARDIS.com Safety Information USE IN PREGNANCY When used in pregnancy during the second and third trimesters,drugs that act directly on the ...

Eurand's Zentase Effective in Treating Exocrine Pancreatic Insufficiency, Studies Show

...to test Zentase in EPIpatients presenting with the full range of disease severity. Thestudies included pat...ds for pancreatic enzyme products (will get full reference) CONTACT: Marian Cutler, Eurand, +1-973-517-0519 Web site: <a target="_blank" href="...

New Study Shows That telmisartan has Greater Renoprotective Potential Thanlosartan in Hypertensive Patients With Type 2 Diabetes

...ful and consistent blood pressurereduction over a full 24 hour period.(7-10) About Telmisartan(Micardis(R)/Kinzal(R)/Pritor(R)) Telmisartan is a member of the angiotensin II receptorblocker (ARB) class and is being investigated in the mostambitious and far-reaching research programme ever c...

First single breast cancer study to show significant survival benefit for women switching from tamoxifen to Arimidex

...k:benefit profile compared with tamoxifen over the full 5 yeartreatment period and beyond, and should establish anastrozole asthe emerging gold standard of care for postmenopausal women withearly breast cancer. 2 - Ends - Notes to editors: * ATAC – ‘Arimidex’, Tamoxifen, Alone or inCo...

Hypertension Vaccine CYT006-AngQb Achieves Strong Blood Pressure Reduction During Important Early Morning Period When Most Adverse Cardiovascular Events Occur

... Current hypertension therapy therefore aims at a full 24-hour bloodpressure control. Commonly used angiotensin II receptor blockers(ARBs) were reported to achieve an ambulatory blood pressurereduction from baseline in the early morning hours of (SBP / DPB) -8.7 / - 5.8 mm Hg (valsartan) and - 11.0 / - 7...

Novelos Therapeutics Announces Encouraging Results in Ongoing Phase 2 Ovarian Cancer Trial at Dana-Farber/Partners Cancer Care

...f Novelos. "Meanwhile,Novelos remains on-track for full enrollment of our pivotal Phase 3trial of NOV-002 for lung cancer in the first quarter 2008." According to the American Cancer Society, in 2006 approximately20,000 U.S. women were expected to be diagnosed with ovarian cancerand 15,000 women were exp...

Salix Pharmaceuticals Announces Positive Top Line Results of Balsalazide Tablets Registration Study

...additional indications are under development. For full prescribing information on Salix products, please visitwww.salix.com. Salix trades on the NASDAQ Global Market under the ticker symbol"SLXP". For more information please contact the Company at 919-862-1000or visit our web site at www.salix.com. Inf...

Anastrozole (Arimidex) Improves Overall Survival in Postmenopausal Women with Early Breast Cancer Receiving Treatment with Tamoxifen

...sk:benefit profilecompared with tamoxifen over the full 5 year treatment period andbeyond, and should establish anastrozole as the emerging goldstandard of care for postmenopausal women with early breast cancer.2 ARNO 95 Trial Design · A prospective, randomised,open-label, parallel group, multi-ce...

Remicade Two Year Data in Ankylosing Spondylitis Show Improvement in Spinal Mobility and Spinal Inflammation

...ve CD in patients who have not responded despite a full andadequate course of therapy with a corticosteroi...ive CD in patients who havenot responded despite a full and adequate course of therapy withconventional treatment (including antibiotics, drainage andimmuno...

Investigational Study Demonstrated a Re-Establishment of Clinical Improvement with Orencia (Abatacept) in Children with Juvenile Idiopathic Arthritis upon Re-Introduction of Therapy

...e modulator of a co-stimulatory signalrequired for full T-cell activation and works in a fundamentallydifferent way than cytokine antagonists, including TNFantagonists. Bristol-Myers Squibb Company is a global pharmaceutical andrelated health care products company whose mission is to extend andenhance hu...

Haemacure Announces Preliminary Findings of its Plasma Discard Analysis

...As advised, these findings are preliminary and the full value ofthese proteins and enzymes cannot be realized without FDA approval.Haemacure will continue identification work on its plasma discardand seek partnerships with pharmaceutical and biotechnologycompanies that would fund the development and clini...

Anti-TNF Golimumab Continues to Show Promise in Phase II Rheumatoid Arthritis Study

...imumab maintained its efficacy over thecourse of a full year is very encouraging,” said Robert J.Spiegel, M.D., chief medical officer and senior vice president,Schering-Plough Research Institute. “Schering-Plough isa leader in bringing forward innovative therapies, such asGolimumab, to patien...

Enbrel Safety Data for up to Eight Years in Patients with Juvenile Rheumatoid Arthritis Being Presented at EULAR

...e sure todiscuss them with your doctor. Please see full PrescribingInformation at www.enbrel.com or call 1... Additional information about ENBREL, includingthe full U.S. Prescribing Information, can be found on the Web sitesponsored by the companies at www.enbrel.c...

Women Well-Informed About Breast Cancer, Yet Lacking Knowledge About Current Treatments, New Survey Finds

...Where do I go for support when I needit? For full survey results, visit <a target="_blank"href="http://www.cancercare.org/">www.cancercare.org . About the survey The survey, sponsored by CancerCare andadministered by GfK Roper Public Affairs was conducted betweenApril 23 and May 9, 2007 vi...

Critical Therapeutics Announces the Publication of Data for ZyfloCR (Zileuton) Extended-Release Tablets in the Journal of Asthma

...pain, upset stomach and nausea, respectively. For full prescribing information for ZYFLO CR, please visit...-866-835-8216 to request medical information. For full prescribing information for ZYFLO, please visitwww.zyflo.com or call the Company's toll free telepho...

July Issue of Journal of Antimicrobial Chemotherapy Highlights Study of Factive Tablets for Five-Day Treatment of Community-Acquired Pneumonia

...arding the safety and use ofANTARA, please see the full prescribing information available atwww.antararx.c...ete safetyand efficacy information, please see the full prescribinginformation available at www.factive.com. Forward-Looking Statement This news release c...

Vion Pharmaceuticals Presents Clinical Data from a Phase II Trial of Cloretazine (VNP40101M) in Elderly AML Patients with Unfavorable Cytogenetics at EHA Meeting

...ltrials, that any of these trials will continue to full accrual, orthat any of these trials will not be discontinued, modified,delayed or ceased altogether. Except in special circumstances inwhich a duty to update arises under law when prior disclosurebecomes materially misleading in light of subsequent e...

Pivotal Phase III Trial Showed Promacta (eltrombopag olamine) Raised Platelet Counts and Reduced Bleeding in Patients With Chronic ITP

...It can prevent cancer patients fromreceiving their full dose of chemotherapy on schedule, precludepatients with hepatitis C infection from receiving interferontherapy or lead to dose reductions or discontinuation of therapy,and complicate surgical or dental procedures.(11,12) About GlaxoSmithKline Glaxo...

Medivation's Dimebon Maintains Statistically Significant Benefit on All Five Efficacy Endpoints in Alzheimer's Disease Trial After One Year of Therapy

...ng that their levelof function was preserved for a full year on all five endpoints.The endpoints spanned a...cts of mild-to-moderateAlzheimer's disease after a full year of therapy. Given these dataand the fact that Dimebon was well tolerated in this study, Iconsid...

Studies Show Efficacy and Safety of Alexion's Soliris in Broad Population of PNH Patients

...s in the year prior toSoliris treatment." For the full abstracts of these presentations, please visit the...gfor detection of new safety findings. Please see full prescribing information at <a target="_blank"href="http://www.soliris.net/">http://www.solir...

Trial Results with Intranasal Fentanyl Hold Promise for Treatment of Breakthrough Pain in Cancer

...ghpain.eu/">www.breakthroughpain.eu wherealso full details of all presentations from the ‘Challengesin treating breakthrough pain’ satellite symposium can befound. <p style="MARGIN: 0in 0in 0pt; TEXT-INDENT: 0.25in; LINE-HEIGHT: 150%"> About Nycomed Nycomed is an internationa...

AVANIR Pharmaceuticals Presents Zenvia Phase III Data in Diabetic Peripheral Neuropathic Pain at International Congress on Neuropathic Pain

...withschizophrenia or schizoaffective disorder. For full prescribinginformation and important safety information regarding FazaClo,please visit www.fazaclo.com. AVANIR's lead product candidate forthe treatment of involuntary emotional expression disorder (IEED),Zenvia, is the subject of an approvable lette...

To Stent or Not: Is That the Question?

...thing has really changed." COURAGE isshort for the full study name Clinical Outcomes UtilizingRevascularization and Aggressive Guideline Driven DrugEvaluation. Many consumers have misread stories in the press about stentsand angioplasty as involving patients undergoing a heart attack andin dire need of e...

Extensive Clinical Data on Erbitux Presented at the 2007 ASCO Annual Meeting

...C cancer is based on objectiveresponse rates. For full prescribing information, including boxed WARNINGSregarding infusion reactions and cardiopulmonary arrest, visithttp://www.ERBITUX.com. Important Safety Information: Grade 3/4 infusion reactions, rarely with fatal outcome (lessthan 1 in 1000), occur...

MGI Pharma Summarizes Data Presented at the 2007 American Society of Clinical Oncology (ASCO) Annual Meeting

..."http://www.gliadel.com/">www.gliadel.com for full prescribinginformation. About MGI PHARMA MGI PHARMA, INC. is a biopharmaceutical company focused inoncology and acute care that acquires, researches, develops andcommercializes proprietary products that address the unmet needs ofpatients. MGI PHARM...

Clinical Data Reported on Vidaza in Hematologic Malignancies and Advanced Solid Tumors

...ne or preliminary results maynot be confirmed upon full analysis of the detailed results of atrial and add...ne or preliminary results may not be confirmedupon full analysis of the detailed results of a trial andadditional information relating to the safety, effica...

Study Shows Advantages of Complete Phase Ib Trial Over Separate Phase I Trials

...dy to EGFR + NA. The standard agent is started at full dose with three patientsplaced at 1/3 full dose of NA, three patients at 2/3 dose of NA,and three-six patients at full dose of the NA in the co...

MGI Pharma, Inc. Summarizes Data Presented at the 2007 American Society of Clinical Oncology (ASCO) Annual Meeting

...ease visitwww.mgipharma.com or www.dacogen.com for full prescribinginformation. About Gliadel(R) Wafer G...mal wound healing. Pleasevisit www.gliadel.com for full prescribing information. About MGI PHARMA MGI PHARMA, INC. is a biopharmaceutical company focused ...

Updated Study Results Reinforce Survival Benefit of Taxotere (Docetaxel) for Men with Advanced, Hormone-Resistant Prostate Cancer

...read, that rate goes down dramatically to33%. For full prescribing information, including boxed WARNING, call800-633- 1610 or visit <a target="_blank" href="http://www.taxotere.com/">www.taxotere.com . About sanofi-aventis Sanofi-aventis is one of the world leaders in the pharmaceuticalindustry...

Ontak (denileukin diftitox) Achieves 49.1% Overall Response Rate in Phase III Trial of Cutaneous T-Cell Lymphoma (CTCL)

...: Visual Loss For detailed safety information and full prescribing informationabout ONTAK(R) (denileukin diftitox), please see attachedprescribing information or visit <a target="_blank" href="http://www.eisai.com/">www.eisai.com . About Eisai Inc. Eisai Inc. is a U.S. pharmaceutical subsidiary...

Phase 2 Clinical Results of Ganite Plus Standard Therapy in Patients with Relapsed/Refractory Lymphoma Presented at ASCO

...veral days is recommended. Please see accompanying full Prescribing Information in the PackageInsert or on the Ganite website at <a target="_blank" href="http://www.ganite.com/">www.ganite.com . About Genta Genta Incorporated is a biopharmaceutical company with adiversified product portfolio that...